About Us

Every day, in operating rooms around the world, surgeons are faced with challenging repairs and reconstructions of soft tissues in cancer, trauma, diabetic, burn, and sports medicine patients. For their most challenging repairs, surgeons choose TEI Biosciences’ novel biologic products for superior clinical outcomes.

Previous Tab Next Tab

Clinical Evidence

Bovine vs Porcine Acellular Dermal Matrix for Complex Abdominal Wall Reconstruction.

American Society of Plastic and Reconstructive Surgery Learn More

Clinical Evidence

Improvement of Success Rates for Abdominal Component Reconstructions Using Bovine Fetal Collagen

Annals of Plastic Surgery Learn More

A Case Study

Acellular Bovine-Derived Matrix Used on a Traumatic Crush Injury of the Hand

Ostomy Wound Management Learn More

News + Events

February 21, 2013

TEI Biosciences Inc. (“TEI”) announced today that its PriMatrix™ dermal repair matrix, indicated for the management of wounds and ulcers, has been formally added to the NGS Medicare LCD L26003 “LCD for Biologic Products for Wound Treatment and A52087 Surgical Interventions”, in Jurisdiction J6 and J13

February 13, 2013

TEI Biosciences Inc. announced today that Yiannis Monovoukas, PhD, MBA, TEI’s Chairman, President, and CEO, will be a presenter at the Canaccord Genuity Musculoskeletal Conference, held on March 19th, 2013, at the Westin Michigan Avenue in Chicago, IL.

  • View More

    • Healthcare Professionals

      Innovative solutions for a broad spectrum of soft tissue repair and regeneration applications.

      Learn More

    • Patients

      TEI Biosciences as a trusted provider of medical devices that enable soft tissue repair and reconstruction.

      Learn More

    • TEI by the Numbers

      Our remarkable story told by numbers.

      Learn More